Results 101 to 110 of about 28,157 (212)

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Turkish Journal of Hematology, 2022
Tekin Guney, Ferda Can, Sema Akıncı, Özge Soyer Kösemehmetoğlu, İmdat Dilek   +4 more
doaj   +1 more source

Superior immunogenicity and effectiveness of the 3rd BNT162b2 vaccine dose [PDF]

, 2021
Yaniv Lustig, Tal Gonen, L. Melzer, Mayan Gilboa, Victoria Indenbaum, Carmit Cohen, Sharon Amit, Hanaa Jaber, Ram Doolman, Keren Asraf, Carmit Rubin, Ronen Fluss, Ella Mendelson, Laurence S. Freedman, Gili Regev‐Yochay, Yitshak Kreiss   +15 more
openalex   +1 more source

The Impact of COVID‐19 on Obstructive Pulmonary Diseases: A Narrative Review of Long‐Term Consequences and Vaccination Strategies

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims The COVID‐19 pandemic has posed significant challenges for individuals with obstructive pulmonary diseases (OPDs), such as asthma and chronic obstructive pulmonary disease (COPD). Emerging evidence highlights the complex interplay between SARS‐CoV‐2 infection and OPDs, including increased risks of severe disease, long‐term ...
Behnam Dalfardi, Hamidreza Abtahi, Maryam Edalatifard, Sedigheh Mozaffari, Besharat Rahimi, Ghazal Roostaei, Niloofar Khoshnam Rad   +6 more
wiley   +1 more source

Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART [PDF]

, 2022
Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, C Stingone, Martina Pontone, Anna Rita Buonomini, Massimo Giuliani, Fulvia Pimpinelli, Aldo Morrone, Alessandra Latini   +9 more
openalex   +1 more source

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies [PDF]

, 2021
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al‐Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Mohamed Abu‐Farha, Jehad Abubaker, Fahd Al‐Mulla   +13 more
openalex   +1 more source

Acute interstitial nephritis after vaccination with BNT162b2 [PDF]

Journal of Nephrology, 2022
Rieckmann, Sonja, Seibert, Felix S., Hogeweg, Maximilian, Bertram, Sebastian, Doevelaar, Adrian A. N., Amann, Kerstin, Babel, Nina, Westhoff, Timm H.   +7 more
openaire   +2 more sources

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors [PDF]

, 2022
Ithai Waldhorn, Roy Holland, Tal Goshen‐Lago, Madeleine Benguigui, Michael Halberthal, Yuval Shaked, Irit Ben‐Aharon   +6 more
openalex   +1 more source

P413 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE) [PDF]

, 2022
Anna Tran, Daniel Tassone, Johannes C. Nossent, Nik S. Ding   +3 more
openalex   +1 more source

Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech) [PDF]

, 2021
Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, H Nakata, Hirofumi Chiba   +6 more
openalex   +1 more source

Hybrid immunity of the SARS-CoV-2 vaccine after the third doses in health workers

Revista Habanera de Ciencias Médicas
Introduction: Hybrid immunity is the immune response of people infected with COVID-19 who received the SARS-CoV-2 vaccine. This combination is more powerful than the immunity that is generated after vaccination or infection alone.
Raúl Montalvo, Kelina Almora-León, Anibal Diaz-Lazo, Jorge Montalvo, MÁ Tresierra-Ayala, Sharol Aliaga-Córdova   +5 more
doaj